Cerebellar rTMS in PSP: a Double-Blind Sham-Controlled Study Using Mobile Health Technology

被引:0
|
作者
Andrea Pilotto
Maria Cristina Rizzetti
Alberto Lombardi
Clint Hansen
Michele Biggi
Giacomo Verzeroli
Antonella Martinelli
Robbin Romijnders
Barbara Borroni
Walter Maetzler
Alessandro Padovani
机构
[1] University of Brescia,Neurology Unit, Department of Clinical and Experimental Sciences
[2] FERB Onlus Trescore Balneario,Parkinson’s Disease Rehabilitation Unit
[3] Christian-Albrechts-University of Kiel,Department of Neurology
[4] Milano Bicocca University,Physical Therapy Unit
来源
The Cerebellum | 2021年 / 20卷
关键词
Progressive supranuclear palsy; Repetitive transcranial magnetic stimulation; Mobile health technology; Postural instability;
D O I
暂无
中图分类号
学科分类号
摘要
There are no effective treatments in progressive supranuclear palsy (PSP). The aim of this study was to test the efficacy of theta burst repetitive transcranial magnetic stimulation (rTMS) on postural instability in PSP. Twenty PSP patients underwent a session of sham or real cerebellar rTMS in a crossover design. Before and after stimulation, static balance was evaluated with instrumented (lower back accelerometer, Rehagait®, Hasomed, Germany) 30-s trials in semitandem and tandem positions. In tandem and semitandem tasks, active stimulation was associated with increase in time without falls (both p=0.04). In the same tasks, device-extracted parameters revealed significant improvement in area (p=0.007), velocity (p=0.005), acceleration and jerkiness of sway (p=0.008) in real versus sham stimulation. Cerebellar rTMS showed a significant effect on stability in PSP patients, when assessed with mobile digital technology, in a double-blind design. These results should motivate larger and longer trials using non-invasive brain stimulation for PSP patients.
引用
收藏
页码:662 / 666
页数:4
相关论文
共 50 条
  • [31] Feasibility and Tolerability of Daily Theta Burst Stimulation in Autistic Youth with Intellectual Disabilities and Minimally Speaking Status: A Pilot Double-Blind Randomized Sham-Controlled Trial
    Ni, Hsing-Chang
    Chen, Yi-Lung
    Lin, Hsiang-Yuan
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2024,
  • [32] Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: A double-blind, randomized, sham-controlled trial
    Huang, Man-li
    Luo, Ben-yan
    Hu, Jian-bo
    Wang, Shan-Shan
    Zhou, Wei-hua
    Wei, Ning
    Hu, Shao-hua
    Xu, Yi
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (03) : 257 - 264
  • [33] Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials
    Berlim, M. T.
    van den Eynde, F.
    Tovar-Perdomo, S.
    Daskalakis, Z. J.
    PSYCHOLOGICAL MEDICINE, 2014, 44 (02) : 225 - 239
  • [34] Repetitive transcranial magnetic stimulation combined with cognitive behavioral therapy treatment in alcohol-dependent patients: A randomized, double-blind sham-controlled multicenter clinical trial
    Hu, Xiaorui
    Zhang, Tian
    Ma, Hongkun
    Zhou, Xuhui
    Wang, Hongxuan
    Wang, Xiaohong
    Cheng, Chang
    Li, Yanfei
    Duan, Ranran
    Zhang, Bo
    Wang, Huaizhi
    Lu, Jia
    Kang, Chuanyi
    Zhao, Na
    Zhang, Yingjie
    Tian, Lu
    Liu, Jun
    Shi, Jingjing
    Wang, Zhe
    Zhou, Xinxin
    Zhu, Shuang
    Liu, Qingxia
    Li, Xuemin
    Wang, Honghui
    Nie, Mingxuan
    Yang, Mei
    Yang, Jianzhong
    Chi, Yong
    Zhu, Xiaofeng
    Hu, Jian
    Jia, Yanjie
    Peng, Ying
    Liu, Lei
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [35] Ultra-High-Frequency Left Prefrontal Transcranial Magnetic Stimulation as Augmentation in Severely Ill Patients with Depression: A Naturalistic Sham-Controlled, Double-Blind, Randomized Trial
    Ullrich, Heiko
    Kranaster, Laura
    Sigges, Erich
    Andrich, Juergen
    Sartorius, Alexander
    NEUROPSYCHOBIOLOGY, 2012, 66 (03) : 141 - 148
  • [36] Low-frequency repetitive transcranial magnetic stimulation over the right orbitofrontal cortex for patients with first-episode schizophrenia: A randomized, double-blind, sham-controlled trial
    Hu, Qiang
    Jiao, Xiong
    Zhou, Jie
    Tang, Yingying
    Zhang, Tianhong
    Song, Chuanfu
    Wang, Junjie
    Xiao, Qiang
    Ye, Junying
    Sun, Junfeng
    Wang, Xijin
    Li, Chunbo
    Wang, Jijun
    PSYCHIATRY RESEARCH, 2023, 330
  • [37] Repetitive Transcranial Magnetic Stimulation Over the Dorsolateral Prefrontal Cortex for Treating Posttraumatic Stress Disorder: An Exploratory Meta-Analysis of Randomized, Double-Blind and Sham-Controlled Trials
    Berlim, Marcelo T.
    Van den Eynde, Frederique
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (09): : 487 - 496
  • [38] Anterior-temporal hippocampal network mechanisms of left angular gyrus-navigated rTMS for memory improvement in aMCI: A sham-controlled study
    Lv, Tingyu
    Chen, Ya
    Hou, Xinle
    Qin, Ruomeng
    Yang, Zhiyuan
    Hu, Zheqi
    Bai, Feng
    BEHAVIOURAL BRAIN RESEARCH, 2024, 471
  • [39] Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study
    Cheng, Chih-Ming
    Hong, Chen-Jee
    Lin, Hui-Ching
    Chu, Po-Jui
    Chen, Mu-Hong
    Tu, Pei-Chi
    Bai, Ya-Mei
    Chang, Wen-Han
    Juan, Chi-Hung
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Su, Tung-Ping
    Li, Cheng-Ta
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 297 : 353 - 359
  • [40] C-STIM: Protocol for a randomized, single-blind, crossover study of cerebellar repetitive transcranial magnetic stimulation (rTMS) for postural instability in people with progressive supranuclear palsy (PSP)
    Dale, M. L.
    Mancini, M.
    Stevens, A.
    Brumbach, B. H.
    Prewitt, A.
    Harker, G.
    Silva-Batista, C.
    Ragothaman, A.
    Folmer, R. L.
    Quinn, J. F.
    Horak, F. B.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 35